Table 1.

Clinicopathological and molecular characteristics in examined Lung Carcinoma.

Characteristics	N = 1153
Sex
Male	686 (59.5%)
Female	467 (40.5%)
Age (years)	23-89 (average 69.3)
Smoking
No	444 (38.5%)
Yes	709 (61.5%)
Stage
0-I	789 (68.4%)
II	182 (15.8%)
III	155 (13.4%)
IV	27 (2.3%)
Histopathology
Adenocarcinoma	846 (73.4%)
Squamous cell carcinoma	242 (21.0%)
Others	65 (5.6%)
Small cell carcinoma	13 (1.1%)
Adenosquamous carcinoma	13 (1.1%)
Large cell carcinoma	10 (0.9%)
Pleomorphic carcinoma	9 (0.8%)
Carcinoid	8 (0.7%)
Large cell neuroendocrine carcinoma	7 (0.6%)
Combined small cell carcinoma	2 (0.2%)
Adenoid cystic carcinoma	2 (0.2%)
Mucoepidermoid carcinoma	1 (0.1%)
PD-L1 protein expression
No expression	933 (80.9%)
Low expression	106 (9.2%)
High expression	114 (9.9%)
p53 protein expression
Negative expression	726 (63.0%)
Positive expression	427 (37.0%)